Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status

Growth Hormone and IGF Research

Volumn 25, Issue 1, 2015, Pages 28-33

  Savastano, Silvia ^a   Di Somma, Carolina ^b   Colao, Annamaria ^a   Barrea, Luigi ^c   Orio, Francesco ^d   Finelli, Carmine ^e   Pasanisi, Fabrizio ^a   Contaldo, Franco ^a   Tarantino, Giovanni ^f  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS SDN   (Italy)

^c IOS   (Italy)

^d UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^e Stella Maris Mediterraneum Foundation   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Body composition; Cardio metabolic risk; GH IGF 1 axis; Serum Sirtuin 4

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIRTUIN 4; SOMATOMEDIN C; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; IGF1 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; SIRT4 PROTEIN, HUMAN; SIRTUIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOMETABOLIC RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FAT MASS; FEMALE; GLUCOSE METABOLISM; GROWTH HORMONE RELEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; LIPID METABOLISM; MALE; METABOLIC PARAMETERS; MITOCHONDRIAL RESPIRATION; OBESITY; PROTEIN EXPRESSION; PSORIASIS; RHEUMATOID ARTHRITIS; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; CASE CONTROL STUDY; GLUCOSE BLOOD LEVEL; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; RISK FACTOR; STATISTICAL MODEL;

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; MALE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OBESITY; OXIDATION-REDUCTION; RISK FACTORS; SIRTUINS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84920267441     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2014.10.006     Document Type: Article

References (29)

1. Vijayakumar A., Yakar S., LeRoith D. The intricate role of growth hormone in metabolism. Front. Endocrinol. (Lausanne) 2011, 2:32-43.
2. Vijayakumar A., Wu Y., Buffin N.J., Li X., Sun H., Gordon R.E., Yakar S., LeRoith D. Skeletal muscle growth hormone receptor signaling regulates basal, but not fasting-induced, lipid oxidation. PLoS One 2012, 7:e44777.
3. Short K.R., Moller N., Bigelow M.L., Coenen-Schimke J., Nair K.S. Enhancement of muscle mitochondrial function by growth hormone. J. Clin. Endocrinol. Metab. 2008, 93:597-604.
4. Garten A., Schuster S., Kiess W. The insulin-like growth factors in adipogenesis and obesity. Endocrinol. Metab. Clin. North Am. 2012, 41:283-295.
5. Berryman D.E., Glad C.A., List E.O., Johannsson G. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat. Rev. Endocrinol. 2013, 9:346-356.
6. Cordido F., Garcia-Buela J., Sangiao-Alvarellos S., Martinez T., Vidal O. The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors. Mediat. Inflamm. 2010, 2010:434-562.
7. Bredella M.A., Utz A.L., Torriani M., Thomas B., Schoenfeld D.A., Miller K.K. Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis. J. Appl. Physiol. 2009, 106:418-422. ((1985)).
8. Savastano S., Di Somma C., Belfiore A., Guida B., Jr Orio F., Rota F., Savanelli M.C., Cascella T., Mentone A., Angrisani L., Lombardi G., Colao A. Growth hormone status in morbidly obese subjects and correlation with body composition. J. Endocrinol. Investig. 2006, 29:536-543.
9. Di Somma C., Pivonello R., Pizza G., De Rosa A., Lombardi G., Colao A., Savastano S. Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency. J. Endocrinol. Investig. 2010, 33:171-177.
10. Haigis M.C., Sinclair D.A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 2010, 5:253-295.
11. Ahuja N., Schwer B., Carobbio S., Waltregny D., North B.J., Castronovo V., Maechler P., Verdin E. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J. Biol. Chem. 2007, 282:33583-33592.
12. Song R., Xu W., Chen Y., Li Z., Zeng Y., Fu Y. The expression of Sirtuins 1 and 4 in peripheral blood leukocytes from patients with type 2 diabetes. Eur. J. Histochem. 2011, 55:e10.
13. Verdin E., Hirschey M.D., Finley L.W., Haigis M.C. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem. Sci. 2010, 35:669-675.
14. Tarantino G., Savastano S., Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J. Gastroenterol. 2010, 16:4773-4783.
15. Medina-Gómez G. Mitochondria and endocrine function of adipose tissue. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26:791-804.
16. Tarantino G., Finelli C., Scopacasa F., Pasanisi F., Contaldo F., Capone D., Savastano S. Circulating levels of Sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes. Oxidative Med. Cell. Longev. 2014, 10.1155/2014/920676.
17. American Diabetes Association Standards of medical care in diabetes-2014. Diabetes Care 2014, 37:S17-S80.
18. Colao A., Di Somma C., Cascella T., Pivonello R., Vitale G., Grasso L.F., Lombardi G., Savastano S. Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur. J. Endocrinol. 2008, 159:389-397.
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Amato M.C., Giordano C., Galia M., Criscimanna A., Vitabile S., Midiri M., Galluzzo A., AlkaMeSy Study Group Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010, 33:920-922.
21. Ghigo E., Aimaretti G., Gianotti L., Bellone J., Arvat E., Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur. J. Endocrinol. 1996, 134:352-356.
22. Corneli G., Di Somma C., Baldelli R., Rovere S., Gasco V., Croce C.G., Grottoli S., Maccario M., Colao A., Lombardi G., Ghigo E., Camanni F., Aimaretti G. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur. J. Endocrinol. 2005, 153:257-264.
23. Molitch M.E., Clemmons D.R., Malozowski S., Merriam G.R., Vance M.L. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96:1587-1609.
24. Stanley T.L., Feldpausch M.N., Murphy C.A., Grinspoon S.K., Makimura H. Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity. Growth Hormon. IGF Res. 2014, 24:10-15.
25. Nasrin N., Wu X., Fortier E., Feng Y., Bare O.C., Chen S., Ren X., Wu Z., Streeper R.S., Bordone L. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 2010, 285:31995-32002.
26. Laurent G., German N.J., Saha A.K., de Boer V.C., Davies M., Koves T.R., Dephoure N., Fischer F., Boanca G., Vaitheesvaran B., Lovitch S.B., Sharpe A.H., Kurland I.J., Steegborn C., Gygi S.P., Muoio D.M., Ruderman N.B., Haigis M.C. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol. Cell 2013, 50:686-698.
27. Liesa M., Shirihai O.S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013, 17:491-506.
28. Peinado J.R., Diaz-Ruiz A., Frühbeck G., Malagon M.M. Mitochondria in metabolic disease: getting clues from proteomic studies. Proteomics 2014, 4-5:452-466.
29. Schrauwen P., Hesselink M.K. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004, 53:1412-1417.